Sign up
Quantellect · Congress · Issuer Profile
NASDAQ: IBRXImmunitybio Inc
HealthcareMkt Cap $8.79BCongress ownership rank #2742

Immunitybio Inc Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 3 trades in Immunitybio Inc (NASDAQ: IBRX) since 2023, across 2 members, worth an estimated $24.00K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 2 buys against 1 sell, a modestly buy-led skew, with Democratic members responsible for 33% of the trades and Republican members 67%. The most recent disclosure shown was filed October 2026, and Lisa McClain has filed the most IBRX transactions among those shown, with 2. One notable disclosed move was a purchase by Lisa McClain on September 30, 2026, down 29.0% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Immunitybio Inc's current Quantellect Tide Score is 39 out of 100 (Calm Tide), Bottom 19% of universe (3865); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Immunitybio Inc (IBRX) stock overview and the complete trade table below.

Data updated

Trades
2
Politicians
1
Filings
1
Disclosed Vol
$16.00K
Buys
2
100%
Sells
0
0%

Price & congressional trade timeline

Party breakdown

Immunitybio congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturnOwner
Oct 12, 2026Sep 30, 202612 daysBuy
$1,001 - $15,000
-29.03%Spouse
Oct 12, 2026Sep 28, 202614 daysBuy
$1,001 - $15,000
-21.36%Spouse
Go to

Immunitybio (IBRX) congressional trading FAQ

Can members of Congress legally trade Immunitybio (IBRX) stock?

Yes. Members of Congress are permitted to trade individual stocks, including Immunitybio (IBRX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.

Are congressional Immunitybio (IBRX) trades public?

Yes. Every congressional trade in Immunitybio (IBRX) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded Immunitybio (IBRX)?

Members of Congress have disclosed 3 trades in Immunitybio (IBRX) worth $24.00K across 2 members, according to public STOCK Act filings.

Which members of Congress have traded Immunitybio (IBRX)?

Recent and active filers of Immunitybio (IBRX) disclosures include Lisa McClain. The full member-by-member trade list is on this page.

Do Democrats or Republicans trade Immunitybio (IBRX) more?

Across disclosed Immunitybio (IBRX) trades, 33% were by Democrats and 67% by Republicans, led by Republicans (67%).

What is the most recent congressional Immunitybio (IBRX) trade?

The most recent disclosed Immunitybio (IBRX) filing reported a buy by Lisa McClain, filed Oct 11, 2026.

What is Immunitybio (IBRX)'s Tide Score?

Immunitybio (IBRX) has a Quantellect Tide Score of 39 (Calm Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.

Browse all stocks Congress tradesCongressional trading overviewImmunitybio (IBRX) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.